Pilot Study to Describe the Trajectory of Symptoms and Adaptive Strategies of Adults Living with Low-grade Glioma.

This was a pilot with only 15 patients, so it cannot show how common these symptoms or strategies are in all adults with low-grade glioma. No control group or intervention was tested, so changes in fatigue or quality of life cannot be attributed to any treatment. Participants had Karnofsky performance status of at least 70%, so the study did not include patients who needed more help with daily activities. Data collection began about 2 months after diagnosis, so it did not capture the first 2 months when patients were mainly dealing with diagnosis and treatment decisions. Biomarker analyses were descriptive, and combinations were not analysed because the sample was too small. Interviews were conducted by advanced practice nurses, and the authors noted that some patients seemed to benefit from the interview process itself. The sample was mostly white, mostly female, and mostly had right frontal tumors, so it may not represent all adults with low-grade glioma.

The supplied text does not include an author conflicts-of-interest statement. The publication types indicate NIH extramural and non-U.S. government research support.

Do not read the fatigue improvement or the high percentages for adaptive strategies as proof that a treatment or nurse education changed outcomes. This was a 15-patient descriptive pilot with no control group, and the study did not test whether the strategies caused improvement.